Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nature’s Sunshine Products, Inc. filings document the public-company record for a Nasdaq-listed Utah corporation that manufactures and markets herbal and nutritional supplements and personal care products. Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, material-event disclosures, executive appointments, compensatory arrangements, material agreements and capital-structure updates for NATR common stock.
Proxy materials cover board elections, governance practices, executive compensation, equity awards, pay-versus-performance disclosure and shareholder voting matters. The filing record also addresses risk, regulatory and business disclosures related to the company’s global wellness product operations and distribution markets.
Natures Sunshine Products executive Kevin R. Herbert, EVP & President, North America, sold a total of 2,000 Common Shares in open-market transactions on June 12, 2026. The shares were sold at prices of about $20.63 and $20.75 per share, and he remains a direct shareholder.
Natures Sunshine Products executive Bryant J. Yates, EVP & President, Europe, reported an open-market sale of 11,968 Common Shares on June 5, 2026 at an average price of $19.90 per share. After this transaction, he directly holds 77,446 Common Shares.
Natures Sunshine Products executive Daniel C. Norman, EVP & President, Asia, sold 9,713 Common Shares in an open-market transaction at $20.64 per share. After this sale, he directly holds 47,276 Common Shares, indicating he retains a substantial ongoing equity stake in the company.
NATURES SUNSHINE PRODUCTS INC executive vice president and general counsel Nathan G. Brower reported an open-market sale of 12,015 common shares at $21.84 per share on May 21, 2026. After this transaction, he directly holds 43,438 common shares.
Fasching Steven J. reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC director Steven J. Fasching received an equity award of 4,500 restricted stock units (RSUs). Each RSU represents the right to receive one common share of NATR stock. These RSUs vest on the earlier of one year from the grant date of May 15, 2027 or the company’s annual shareholder meeting. Following this grant, Fasching holds 15,369 common shares directly.
NATURES SUNSHINE PRODUCTS INC director Heidi Wissmiller reported an equity award. She acquired 4,500 common share units on a Form 4, recorded as a grant/award at a price of $0.0000 per share. These are structured as restricted stock units, each representing one share of common stock.
The RSUs vest on the earlier of one year from the grant date, stated as May 15, 2027, or the occurrence of the company’s annual shareholder meeting. After this grant, Wissmiller directly holds 41,667 common shares, reflecting her current reported equity stake in the company.
Yates Bryant J reported acquisition or exercise transactions in this Form 4 filing.
Natures Sunshine Products Inc executive Bryant J. Yates, EVP & President, Europe, received an equity award of 8,753 common shares in the form of restricted stock units. The Form 4 shows these RSUs were granted at a stated price of $0.00 per share as part of compensation.
After this grant, Yates holds a total of 89,414 common shares directly. According to the footnote, each RSU represents one common share and will vest in three equal annual installments through May 15, 2029, tying the award to multi-year service and performance at the company.
Natures Sunshine Products Inc reported that EVP and General Counsel Nathan G. Brower received an equity award of 9,001 Common Shares in the form of restricted stock units. The award was granted at $0.00 per share as compensation, not as an open-market purchase.
Each RSU represents one share of NATR common stock and vests in three equal annual installments through May 15, 2029. After this grant, Brower directly holds 55,453 Common Shares, reflecting a routine compensation-related acquisition rather than a discretionary stock purchase.
May Katie reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC director Katie May received a grant of 4,500 common shares in the form of restricted stock units (RSUs). The RSUs were awarded at no cash cost per share and each unit represents the right to receive one share of NATR common stock.
These RSUs vest on the earlier of one year from the grant date of May 15, 2027 or the occurrence of the company’s annual shareholder meeting. Following this compensation-related award, May’s directly owned common shares reported in this filing total 14,266.
Fritz Erich A reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC executive Fritz Erich A, EVP of Global Supply Chain, received a grant of 9,226 restricted stock units, each representing one common share of NATR at no cash cost per share. These RSUs vest in three equal annual installments through May 15, 2029. Following this equity award, his directly held common share-equivalent holdings reported in this filing total 20,889 shares, aligning his compensation more closely with the company’s long-term stock performance.